Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 248

Results For "TN"

3152 News Found

BMSF names diversity in clinical trials training program after Robert A Winn
Sustainability | April 11, 2022

BMSF names diversity in clinical trials training program after Robert A Winn

The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027


Lonza signs manufacturing deal with Asher Biotherapeutics
Biotech | April 11, 2022

Lonza signs manufacturing deal with Asher Biotherapeutics

Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein


Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility
Clinical Trials | April 11, 2022

Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility

Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics


India Pharmaceutical Market reports revenue decline in March 2022
News | April 10, 2022

India Pharmaceutical Market reports revenue decline in March 2022

Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect


Ministry of Ayush to organise two-day convention on World Homeopathy day
News | April 09, 2022

Ministry of Ayush to organise two-day convention on World Homeopathy day

World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary


Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
Biotech | April 08, 2022

Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells

Essent continues to broaden its highly characterized, low passage primary cell catalog


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation


Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
Biotech | April 08, 2022

Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test

If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes


Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality
News | April 08, 2022

Study reveals over 80 % newly diagnosed diabetic patients have at least one cholesterol abnormality

The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted


BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
News | April 07, 2022

BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022

Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"